Singapore: INC Research, a therapeutically focused clinical research organization (CRO) with a trusted process for deli...
Singapore: In what is proving to be a major setback for the Indian clinical research industry, reports reveal that the w...
Dr Anuradha Rajput, managing director, Icon Central Laboratories, India, has been working with the company since the pas...
The fifth edition of the annual BioSpectrum Asia Pacific clinical research organization (CRO) Survey, which is conduct...
Singapore: Australian drug development company, Biotron, has commenced a landmark phase II human trial of its lead anti...
Singapore: INC Research, a therapeutically focused global clinical research organization (CRO), has implemented Clinical...
Singapore: Kinex Pharmaceuticals and Hanmi Pharmaceutical announced today that the first patient has been enrolled in Ha...
Singapore: Canada-based Quest PharmaTech, a pharmaceutical company developing and commercializing products for the trea...
Singapore: Eurofins Scientific, which provides analytical support to the global pharmaceutical market, has signed an agr...
Singapore: Pharmaceutical Product Development (PPD) has appointed Dr David Johnston as executive vice president of globa...
Singapore: Icon, Ireland-based global provider of outsourced development services to the pharmaceutical, biotechnology a...
Singapore: PRA, a clinical research organization, has opened a second office in China to accommodate its continued expan...
The fifth edition of the annual BioSpectrum Asia Pacific clinical research organization (CRO) Survey, which is conduct...
Singapore: UK-based biopharma company, Xenetic Biosciences, said in a statement that the recruitment process for the tri...
Everything does not seem to be well in the pharmaceutical industry of Asia's third largest economy - India. Although the...
Pharmaceutical and biotechnology companies reap the most benefit from their strategic collaborations, by working with su...
Recruitment and retention of research participants is often the most labor-intensive and difficult component of clinical...
Any regulatory body's primary concern is to provide safe and efficacious medicine at an acceptable healthcare cost to ...
